Consequently, efforts have been redirected toward the exploration of alternative avenues in cancer treatment, focusing on targeting specific DNA secondary structures associated with oncogenes, with particular emphasis on the extensively overexpressed c-myc (7, 8, 9, 10). This evidence concerns the gene MYC and cancer.